Today
Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
a few seconds ago
Alliance Laundry Holdings Inc. Alliance Reports First Quarter 2026 Results
a few seconds ago
Loblaw Releases 2025 Live Life Well® Report Highlighting Progress in Sustainability, Community Support, and Social Impact
a few seconds ago
Foghorn Therapeutics Inc. Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May
a minute ago
Madison Air Solutions Corporation Madison Air Reports First Quarter 2026 Results
a minute ago
Creative Realities, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Information
a minute ago
D-Wave Reports First Quarter 2026 Results
a minute ago
Brookdale Senior Living Inc. Brookdale to Present at the Bank of America Global Healthcare Conference and the RBC Capital Markets Global Healthcare Conference
a minute ago
Colliers International Group Inc. Colliers to partner with specialist engineering and design firm
2 minutes ago
Veritone Reports First Quarter 2026 Results, Reaffirms 2026 Guide of $130-$145 million in Revenue in Fiscal 2026
2 minutes ago
United Therapeutics Corporation United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference
2 minutes ago
Kraft Heinz Celebrates 250 Years of Summer Cookouts with "The United Tastes of America"
3 minutes ago
GenNx360 Capital Partners Completes Sale of Precision Aviation Group to VSE Corporation for Approximately $2.025 Billion in Cash and Equity.
3 minutes ago
Broadwind Announces First Quarter 2026 Results
3 minutes ago
Olema Pharmaceuticals, Inc. Olema Oncology Reports First Quarter 2026 Financial and Operating Results
3 minutes ago
Alkermes Announces Positive Topline Results From REVITALYZ℠ Phase 3 Study Evaluating LUMRYZ® (sodium oxybate) Extended-Release in Adults With Idiopathic Hypersomnia
3 minutes ago
Xylem Releases 2025 Sustainability Report
4 minutes ago
Rigel Pharmaceuticals, Inc. Rigel Enters Exclusive Global Licensing Agreement for VEPPANU™ (vepdegestrant), an oral PROTAC, for the Treatment of 2L+ ER+/HER2-, ESR1m Advanced or Metastatic Breast Cancer
4 minutes ago
Phio Pharmaceuticals Corp. Phio Pharmaceuticals Announces "Innovations in Skin Cancer Treatment and Prevention" in a Fireside Chat with Force Family Office on Tuesday, May 19, 2026
4 minutes ago
Blue Point Brewing Launches Magic Hour IPA—A Bright, Tropical 6% ABV Sipper for Golden Hour
4 minutes ago